Literature DB >> 12517942

Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection.

M Suresh1, Hector Molina, Maria S Salvato, Dimitrios Mastellos, John D Lambris, Matyas Sandor.   

Abstract

In addition to its established role in innate immune mechanisms, complement component C3 is also of critical importance in B cell activation and T cell-dependent Ab responses. In this study, we have examined the requirement for C3 in the generation of primary CD8 T cell responses to an acute systemic viral infection. We compared Ag-specific CD8 T cell responses to lymphocytic choriomeningitis virus (LCMV) between wild-type (+/+) and C3-deficient (C3(-/-)) mice on both 129/B6 and B6 backgrounds. These studies revealed that C3 activity is required for optimal expansion of LCMV-specific effector CD8 T cells in an epitope-dependent fashion, which is influenced by the genetic background of the mice. Studies in complement receptor 1/2 (CR1/CR2)-deficient mice showed that regulation of LCMV-specific CD8 T cell responses by C3 is not dependent upon CR1/CR2. These findings may have implications in vaccine development, therapy of autoimmune diseases, and prevention of graft rejection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517942     DOI: 10.4049/jimmunol.170.2.788

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Virally activated CD8 T cells home to Mycobacterium bovis BCG-induced granulomas but enhance antimycobacterial protection only in immunodeficient mice.

Authors:  Laura H Hogan; Dominic O Co; Jozsef Karman; Erika Heninger; M Suresh; Matyas Sandor
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.

Authors:  Vasile Pavlov; Hugo Raedler; Shuguang Yuan; Staci Leisman; Wing-Hong Kwan; Peter N Lalli; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

Review 4.  Complement regulation of T cell immunity.

Authors:  Wing-hong Kwan; William van der Touw; Peter S Heeger
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.

Authors:  Mark Vieyra; Staci Leisman; Hugo Raedler; Wing-Hong Kwan; Min Yang; Michael G Strainic; M Edward Medof; Peter S Heeger
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

Review 6.  Understanding human thiol dioxygenase enzymes: structure to function, and biology to pathology.

Authors:  Bibekananda Sarkar; Mahesh Kulharia; Anil K Mantha
Journal:  Int J Exp Pathol       Date:  2017-04-24       Impact factor: 1.925

7.  Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.

Authors:  Peter N Lalli; Michael G Strainic; Min Yang; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

8.  Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors:  Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

9.  Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Authors:  Zoltán Bánki; Wilfried Posch; Asim Ejaz; Verena Oberhauser; Suzanne Willey; Christoph Gassner; Heribert Stoiber; Ulf Dittmer; Manfred P Dierich; Kim J Hasenkrug; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 10.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.